Thursday, April 13, 2023

Pharmacology Preconference

Cardiometabolic Treatments for Obesity

  1. Describe the epidemiology, pathophysiology, and history of cardiometabolic conditions
  2. Compare pharmacokinetics of novel and traditional obesity therapeutics which includes patients with Type 2 diabetes (SGLT2is, GLP1s, and GIP/GLP-1 agonist)
  3. Discuss indications for novel weight loss therapies and their cardiac implications
  4. Explain strategies to overcome barriers to medication access

Therapies to Treat Inflammation in Cardiovascular Disease

  1. Review the role of inflammation in cardiovascular risk assessment
  2. Examine the pathophysiology and pharmacokinetics of inflammation reduction
  3. Discuss treatment options for inflammatory conditions
  4. Explore the inter-disciplinary team-based care approach to prescribing and monitoring inflammation and cardiovascular pharmacotherapies

Update on Stroke: Tenecteplase (TNK)

  1. Review research supporting the use of Tenecteplase in acute stroke management
  2. Describe considerations for decreasing door-to-needle time to improve stroke outcomes
  3. Discuss the advantages and contraindications of Tenecteplase use across patient populations
  4. Explain the administration and monitoring of Tenecteplase

Antiplatelet Therapy in Primary Prevention

  1. Review the mechanism of action of antiplatelet therapy
  2. Describe indications for antiplatelet therapy
  3. Explain the risks and benefits of holding the therapy
  4. Discuss novel antiplatelet therapy options

General Sessions

Antiplatelet Therapy in Primary Prevention

  1. Review the mechanism of action of antiplatelet therapy
  2. Describe indications for antiplatelet therapy
  3. Explain the risks and benefits of holding the therapy
  4. Discuss novel antiplatelet therapy options

Evaluating Chest Pain: Cardiac vs. Non-Cardiac

  1. Review updated chest pain guidelines
  2. Discuss assessment and treatment of non-coronary chest pain
  3. Discuss assessment and treatment of coronary chest pain
  4. Explain the importance of shared-decision making in clinically stable patients

Heart Failure Prevention and Treatment: Latest Guidelines

  1. Review HF demographics including the impact of social determinants of health
  2. Examine guideline updates for clinical practice
  3. Discuss diagnosis, imaging, and the new classifications of HF
  4. Explain the CV nurse’s role in the prevention of heart failure

Friday, April 14, 2023

The Role of LP(a) in CVD Risk

  1. Define LP(a)s role in CVD risk
  2. Examine current research in lowering LP(a)
  3. Explore diagnostic testing to confirm LP(a) diagnosis
  4. Discuss treatment options for patients with LP(a) diagnosis

Kidney Health Equity

  1. Review national data on kidney-related health disparities
  2. Discuss literature evaluating the influence of adverse social determinants of health on kidney outcomes
  3. Highlight interventions aimed at addressing kidney-related disparities

Behavioral Interventions: Impact on Cardiovascular Risk Factors

  1. Describe the prevalence of mental health issues in cardiac populations
  2. Summarize the associations between mental health issues and cardiovascular outcomes, including hypothesized mechanisms
  3. Describe best practices for screening and referral for mental health treatment

Structural Heart Interventions: What’s New?

  1. Define structural heart conditions including valvular disease such as aortic stenosis and mitral regurgitation
  2. Review valvular heart disease treatment options including surgery and transcatheter valve options
  3. Review procedural heart interventions including TAVR, TMVR, and TEER
  4. Explain when to refer to a structural heart program including highlighting social determinants of health

Breakout: Cardiac Rehab: What’s in it for You and Your Patients?

  1. Review of cardiac rehab program patient outcome data
  2. Explain which patients are candidates for referral
  3. Discuss novel approaches to cardiac rehabs
  4. Examine a PAD cardiac rehab patient journey

Breakout: CVD Diagnostics: Demystifying which, when, and why?

  1. Define common CVD diagnostic tests
  2. Discuss which tests are appropriate for differing patient complaints
  3. Explain test result interpretation and the importance of team-based care
  4. Explore best practices for the next steps and follow up

Breakout: Rare Arrhythmias: Do you know what to look for?

  1. Review key components of rhythm identification
  2. Review pathophysiology and underlying causes of lethal ventricular arrhythmias including Brugada syndrome and Prolonged QT syndrome, wide QRS
  3. Review pathophysiology and underlying causes of atrial arrhythmias including Atrial Fibrillation, A Flutter, Wolf Parksinsons White syndrome, SVT
  4. Review the team-based approach to diagnosis, treatment, and referral pathways

Saturday, April 15, 2023

Mobilizing Nurses to Reduce Hypertension Burden

  1. Describe HTN in population health including disparities
  2. Review HTN policies
  3. Explain community-based initiatives for hypertension management
  4. Discuss the unique role that nurses play

Hypertrophic Cardiomyopathy: Comparing Traditional & Novel Treatments

  1. Define and diagnose Hypertrophic Cardiomyopathy including non-obstructive and obstructive
  2. escribe the journey of a HCM patient using a case study approach
  3. Review traditional treatment, pharmacological and lifestyle modifications, for HCM
  4. Explore novel pharmacological treatment including the mechanism of action of cardiac myosin inhibitors

Reflecting on Well-Being: Focus on the Health of Nurses

  1. Discuss the importance of well-being and self-care
  2. Examine a well-being program from implementation to sustainability
  3. Review techniques including work-life balance, joy, mood, resiliency, and more
  4. Explain the importance of a sense of community and belonging

Accreditation Statement

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). Multiple educational grants have been requested to support this program. PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. This program was planned in accordance with AANP CE Policies and Commercial Support Standards.